British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.
The late-stage trials of the experimental vaccine, one of the most advanced in development, were suspended this week after an illness in a study subject in Britain.
For more coronavirus news, visit our dedicated page.
“The standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators,” AstraZeneca said.
“The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume.”
The company said it could not disclose further medical information.
“All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards.”
Iran's coronavirus death toll passes 23,000Iran’s coronavirus death toll rose by 116 to 23,029, a health ministry spokeswoman told state TV on Saturday.The total number of identified cases ... Coronavirus
UK’s Birmingham tightens coronavirus restrictions after infection rate risesAuthorities in Britain’s second city of Birmingham announced new coronavirus restrictions Friday as the nation’s viral reproduction rate, or R number, ... Coronavirus
Coronavirus: White House adviser Dr. Fauci sticks with projection of vaccine in 2021The White House adviser on the coronavirus Dr. Anthony Fauci says he’s sticking with his projection that a safe and effective coronavirus vaccine may ... Coronavirus